Business Development | Growth | Nutent Therapeutics
Nutent Therapeutics is committed to strategic growth through targeted product acquisitions and partnerships.
We are actively pursuing external opportunities including in-licensing, out-licensing, co-development and co-marketing that are aligned with our internal areas of expertise and offer significant customer value.
Nutent has executed two separate in-licensing deals to acquire Volt03 and GlucodOX.
Levolta Pharmaceuticals 2
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.